BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 15700845)

  • 21. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study.
    Huang JH; Hsu RB
    Scand J Infect Dis; 2008; 40(6-7):462-7. PubMed ID: 18584532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.
    Wang JL; Chen SY; Wang JT; Wu GH; Chiang WC; Hsueh PR; Chen YC; Chang SC
    Clin Infect Dis; 2008 Mar; 46(6):799-806. PubMed ID: 18266610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of vancomycin, ciprofloxacin, daptomycin, and linezolid against coagulase-negative staphylococci bacteremia.
    Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Rodríguez-Vidigal FF; Vera Tomé A; Robles Marcos M
    Rev Esp Quimioter; 2011 Jun; 24(2):74-8. PubMed ID: 21666998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staphylococcus aureus versus Staphylococcus epidermidis in periprosthetic joint infection-Outcome analysis of methicillin-resistant versus methicillin-susceptible strains.
    Hischebeth GT; Randau TM; Ploeger MM; Friedrich MJ; Kaup E; Jacobs C; Molitor E; Hoerauf A; Gravius S; Wimmer MD
    Diagn Microbiol Infect Dis; 2019 Feb; 93(2):125-130. PubMed ID: 30266398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.
    Kopp BJ; Nix DE; Armstrong EP
    Ann Pharmacother; 2004 Sep; 38(9):1377-82. PubMed ID: 15266044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and microbiological factors associated with early patient mortality from methicillin-resistant Staphylococcus aureus bacteremia.
    Kim T; Chong YP; Park KH; Bang KM; Park SJ; Kim SH; Jeong JY; Lee SO; Choi SH; Woo JH; Kim YS
    Korean J Intern Med; 2019 Jan; 34(1):184-194. PubMed ID: 28859468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing epidemiology of community-onset methicillin-resistant Staphylococcus aureus bacteremia.
    Johnson LB; Bhan A; Pawlak J; Manzor O; Saravolatz LD
    Infect Control Hosp Epidemiol; 2003 Jun; 24(6):431-5. PubMed ID: 12828320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiological comparison of true methicillin-resistant and methicillin-susceptible coagulase-negative staphylococcal bacteremia at hospital admission.
    Tacconelli E; D'Agata EM; Karchmer AW
    Clin Infect Dis; 2003 Sep; 37(5):644-9. PubMed ID: 12942394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus.
    Shurland S; Zhan M; Bradham DD; Roghmann MC
    Infect Control Hosp Epidemiol; 2007 Mar; 28(3):273-9. PubMed ID: 17326017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors and mortality in patients with nosocomial Staphylococcus aureus bacteremia.
    Wang FD; Chen YY; Chen TL; Liu CY
    Am J Infect Control; 2008 Mar; 36(2):118-22. PubMed ID: 18313513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of daptomycin against methicillin- and multi-resistant Staphylococcus haemolyticus invasive isolates carrying different mec complexes.
    Campanile F; Bongiorno D; Borbone S; Falcone M; Giannella M; Venditti M; Stefani S
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):227-31. PubMed ID: 18329218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methicillin-Susceptible Teicoplanin-Resistant Staphylococcus haemolyticus Isolate from a Bloodstream Infection with Novel Mutations in the tcaRAB Teicoplanin Resistance Operon.
    Bakthavatchalam YD; Sudarsanam TD; Babu P; Munuswamy E; Muthuirulandi Sethuvel DP; Devanga Ragupathi NK; Veeraraghavan B
    Jpn J Infect Dis; 2017 Jul; 70(4):458-460. PubMed ID: 28250264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiplex PCR assay to identify methicillin-resistant Staphylococcus haemolyticus.
    Schuenck RP; Pereira EM; Iorio NL; Dos Santos KR
    FEMS Immunol Med Microbiol; 2008 Apr; 52(3):431-5. PubMed ID: 18294192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013.
    Coombs GW; Nimmo GR; Daly DA; Le TT; Pearson JC; Tan HL; Robinson JO; Collignon PJ; McLaws ML; Turnidge JD;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E309-19. PubMed ID: 25631593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tabebuia avellanedae naphthoquinones: activity against methicillin-resistant staphylococcal strains, cytotoxic activity and in vivo dermal irritability analysis.
    Pereira EM; Machado Tde B; Leal IC; Jesus DM; Damaso CR; Pinto AV; Giambiagi-deMarval M; Kuster RM; Santos KR
    Ann Clin Microbiol Antimicrob; 2006 Mar; 5():5. PubMed ID: 16553949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia.
    Moise PA; Sakoulas G; Forrest A; Schentag JJ
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2582-6. PubMed ID: 17452488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nosocomial infection caused by multidrug-resistant Staphylococcus aureus with reduced susceptibility to vancomycin and teicoplanin.--Yamagata Prefecture, Japan; May 2004-Jun 2005].
    Murata T; Otani K
    Kansenshogaku Zasshi; 2007 Mar; 81(2):183-8. PubMed ID: 17447477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different susceptibility of coagulase-positive and coagulase-negative staphylococci to ciprofloxacin.
    Utili R; Tripodi MF; Rosario P; Andreana A; Locatelli A; Rambaldi A; Florio A
    New Microbiol; 1996 Oct; 19(4):309-14. PubMed ID: 8914131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children.
    Martínez-Aguilar G; Hammerman WA; Mason EO; Kaplan SL
    Pediatr Infect Dis J; 2003 Jul; 22(7):593-8. PubMed ID: 12867833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.